Dr. med. Wolfgang Rohrer, Klosters, Switzerland SUMMARY Treating rheumatic disorders with the chemotherapeutic agents known to conventional medicine (methotrexate, leflunomide, etc.) frequently presents difficult problems for the patient as well as the physician. The potential side effects of these drugs, in particular, can be extremely unpleasant for the patient and create real problems for the […]
To access this post, you must purchase Gold Membership, Ai Therapy Protocol Generator, Platinum Membership, Silver Membership or Bronze Membership. Congress Papers are available to Gold and Platinum memberships. The Ai therapy generator includes Gold membership